Parakkal Deepak
Washington University School of Medicine in St. Louis
Appearances
DateMay 6, 2023BACKGROUND: Prevention of postoperative recurrence (POR) in Crohn’s disease (CD) after ileo-colonic (IC) resection is still a highly debated topic. Prophylactic immunosuppression after surgery is currently recommended in presence of at least one clinical risk factor (RF)…Presenter
Icahn School of Medicine Mount Sinai HospitalSpeakers
Washington University School of Medicine in St. LouisMayo Clinic, RochesterIcahn School of Medicine, Mount SinaiUniversity of MichiganUniversity of MarylandUniversity of North CarolinaUniversity of North Carolina School of Medicine- DateMay 19, 2024BACKGROUNDS: Group 3 innate lymphoid cells (ILC3s) have recently emerged as important regulators and potential drug targets for IBD. However, the response of ILC3s to environmental stimuli during intestinal inflammation remains elusive…
Presenter
Speakers
Washington University School of Medicine in St. Louis - DateMay 18, 2024BACKGROUNDS: Perianal fistulas occur in ~30-40% of Crohn’s disease (CD) patients associated with high morbidity and an impaired quality of life. The management of perianal fistulizing CD is a major clinical challenge, where its underlying etiology remains poorly understood…
Presenter
Speakers
- DateMay 18, 2024BACKGROUND & AIMS: After restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC), a subset of patients develop Crohn’s-like disease of the pouch (CDP), an inflammatory condition that affects both the ileoanal pouch and extra-pouch organs including the pre-po…
Presenter
Speakers
Washington University in St LouisWashington University School of Medicine in St. Louis 
DateMay 21, 2024SOCIETY: AGA As our scientific tools improve, so does our ability to link the environment with different aspects of IBD…Moderators
University of ManitobaWashington University School of Medicine in St. Louis
DateMay 6, 2025This session will examine promising emerging biomarkers for prognostication in IBD and define optimal use of existing biomarkers…Moderators
Washington University School of Medicine in St. LouisSinai Health System
